Previous studies have shown that miR-494 can specifically target PTEN, leading to the activation of the PI3K/AKT pathway during various pathophysiologic processes including cell apoptosis, tumor metastasis, and angiogenesis [18,29,30]. Here, PTEN is linked to neoplasm.